STARTUP PROFILE

SetPoint Medical

COUNTRY
USA
FOUNDED
2006
CATEGORY
Neuromodulation
Developing an implantable vagus nerve stimulation system for rheumatoid arthritis through neuroimmune modulation of inflammatory pathways.
Visit website →
Neurofounders Insights
$   Funding   -
Series C+
MODALITY
VNS
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
FDA approved (PMA)
SetPoint Medical sits in one of the more clinically advanced areas of bioelectronic medicine, using implantable VNS to modulate inflammatory pathways in rheumatoid arthritis. Its positioning is notable because it places neuromodulation inside immune-mediated disease, expanding the category beyond conventional neurological applications.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
SetPoint Medical
No items found.